TRVI

$0.00

(

0.00%

)
Quote details

stock

Trevi Therapeutics Inc

NASDAQ | TRVI

11.35

USD

$0.00

(

0.00%

)

At Close (As of Nov 17, 2025)

$1.40B

Market Cap

-

P/E Ratio

-0.37

EPS

$12.30

52 Week High

$2.36

52 Week Low

HEALTHCARE

Sector

TRVI Chart

Recent Chart
Price Action

TRVI Technicals

Tags:

TRVI Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$147K
Total Revenue $0
Cost Of Revenue $147K
Costof Goods And Services Sold $147K
Operating Income -$52M
Selling General And Administrative $12M
Research And Development $39M
Operating Expenses $52M
Investment Income Net -
Net Interest Income $3.6M
Interest Income $3.6M
Interest Expense $4K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $147K
Income Before Tax -$48M
Income Tax Expense -$30K
Interest And Debt Expense -
Net Income From Continuing Operations -$48M
Comprehensive Income Net Of Tax -
Ebit -$48M
Ebitda -$48M
Net Income -$48M

Revenue & Profitability

Earnings Performance

TRVI Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $111M
Total Current Assets $109M
Cash And Cash Equivalents At Carrying Value $34M
Cash And Short Term Investments $34M
Inventory -
Current Net Receivables $532K
Total Non Current Assets $1.5M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $74M
Other Current Assets $1.3M
Other Non Current Assets -
Total Liabilities $11M
Total Current Liabilities $11M
Current Accounts Payable $3.4M
Deferred Revenue -
Current Debt -
Short Term Debt $285K
Total Non Current Liabilities $747K
Capital Lease Obligations $1M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $1M
Other Current Liabilities $6.8M
Other Non Current Liabilities -
Total Shareholder Equity $100M
Treasury Stock -
Retained Earnings -$287M
Common Stock $94K
Common Stock Shares Outstanding $101M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$38M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $147K
Capital Expenditures $35K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$22M
Cashflow From Financing $61M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$48M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$147K
Total Revenue $0
Cost Of Revenue $147K
Costof Goods And Services Sold $147K
Operating Income -$52M
Selling General And Administrative $12M
Research And Development $39M
Operating Expenses $52M
Investment Income Net -
Net Interest Income $3.6M
Interest Income $3.6M
Interest Expense $4K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $147K
Income Before Tax -$48M
Income Tax Expense -$30K
Interest And Debt Expense -
Net Income From Continuing Operations -$48M
Comprehensive Income Net Of Tax -
Ebit -$48M
Ebitda -$48M
Net Income -$48M

TRVI News

TRVI Profile

Trevi Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in New Haven, Connecticut, focused on developing innovative therapies for patients suffering from serious neurology-mediated conditions. The company's lead product candidate, Haduvio, addresses significant unmet medical needs and is currently in clinical trials, reflecting Trevi's commitment to advancing its therapeutic pipeline. Leveraging its expertise in drug development and a strategic focus on commercialization opportunities, Trevi Therapeutics is well-positioned to deliver impactful solutions in the neurology sector, potentially transforming the treatment landscape for affected patients.

WTO
+25.52%
$0.03
LPTX
+368.57%
$2.05
APLT
+30.18%
$0.28
AMIX
+58.18%
$1.15
NVDA
-1.87%
$186.60
ONDS
-12.88%
$6.25
CHR
-2.66%
$0.04
ASST
-3.70%
$1.04
TSLA
+1.13%
$408.92
GLMD
+0.96%
$1.05
PFE
+0.07%
$25.08
SOFI
-2.80%
$27.04
F
-2.35%
$12.88
PLUG
-7.12%
$2.08
DVLT
+1.91%
$1.86
INTC
-2.28%
$34.71
QUBT
+8.49%
$11.50
GNS
-9.87%
$0.77
ACHR
-5.83%
$7.42
VHAI
-25.00%
$0.00
AXDX
-61.36%
$0.03
DNN
-3.62%
$2.39
BYND
-3.70%
$1.04
AMZN
-0.77%
$232.87
BITF
+3.48%
$2.67
RIVN
-1.58%
$14.87
BMNR
-10.02%
$30.95
ETHD
+8.79%
$5.69
DFLI
-1.27%
$0.80
KVUE
-2.61%
$16.22
MARA
-4.00%
$11.51
NIO
-1.29%
$6.08
GOOGL
+3.11%
$285.02
ADAP
-15.14%
$0.05
SNAP
-4.55%
$8.18
PLTR
-1.58%
$171.25
HPE
-7.00%
$21.23
RIG
+1.74%
$4.08
TLRY
-4.62%
$1.03
BURU
-13.34%
$0.21
CIFR
-0.06%
$14.35
AAPL
-1.81%
$267.46
AAL
-3.29%
$12.34
RGTI
-3.10%
$24.69
GRAB
-1.47%
$5.33
WULF
+0.54%
$11.05
ASBP
-14.11%
$0.09
RMBL
+60.50%
$3.21
HOOD
-5.33%
$115.97
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
MSPR
+18.40%
$0.53
AMD
-2.54%
$240.52
WBD
-1.25%
$22.74
BTG
-2.68%
$3.99
BAC
-2.14%
$51.48
CAN
-4.37%
$0.85
XPEV
-10.31%
$22.43
SRM
+53.27%
$10.30
T
-0.46%
$25.47
GOOG
+3.11%
$285.60
NOK
-0.89%
$6.67
IREN
+2.24%
$47.41
SMCI
-6.37%
$34.10
GPUS
-7.60%
$0.27
BBD
-1.63%
$3.62
AMC
-4.82%
$2.17
HIMS
-3.78%
$35.58
PLTD
-1.01%
$6.84
BTBT
-4.56%
$2.30
MU
-1.97%
$241.95
QBTS
-3.30%
$22.83
OWL
-5.81%
$13.77
HBAN
-2.73%
$15.30
BTE
-4.43%
$3.02
SOUN
-6.08%
$11.43
CRWV
-2.62%
$75.33
WLGS
-5.57%
$0.04
CSCO
-0.28%
$77.78
IONZ
-3.07%
$5.04
CLSK
-3.19%
$10.61
VALE
-1.05%
$12.17
MTSR
-0.35%
$70.50
NFLX
-0.83%
$110.29
ABEV
-0.39%
$2.54
APLD
-3.02%
$22.93
EOSE
-5.79%
$13.00
RXRX
-0.48%
$4.12
SMR
-6.19%
$21.06
CLF
+2.23%
$10.97
TWOH
0.00%
$0.00
CRCL
-6.47%
$76.59
AFMD
-34.94%
$0.18
IVVD
+20.85%
$2.84
NBIS
+2.92%
$85.98
QS
-3.57%
$12.95
AMCR
-0.29%
$8.45
KDP
-0.62%
$26.96
JOBY
-3.60%
$13.89
RIOT
-0.50%
$13.88
WTO
+25.52%
$0.03
LPTX
+368.57%
$2.05
APLT
+30.18%
$0.28
AMIX
+58.18%
$1.15
NVDA
-1.87%
$186.60
ONDS
-12.88%
$6.25
CHR
-2.66%
$0.04
ASST
-3.70%
$1.04
TSLA
+1.13%
$408.92
GLMD
+0.96%
$1.05
PFE
+0.07%
$25.08
SOFI
-2.80%
$27.04
F
-2.35%
$12.88
PLUG
-7.12%
$2.08
DVLT
+1.91%
$1.86
INTC
-2.28%
$34.71
QUBT
+8.49%
$11.50
GNS
-9.87%
$0.77
ACHR
-5.83%
$7.42
VHAI
-25.00%
$0.00
AXDX
-61.36%
$0.03
DNN
-3.62%
$2.39
BYND
-3.70%
$1.04
AMZN
-0.77%
$232.87
BITF
+3.48%
$2.67
RIVN
-1.58%
$14.87
BMNR
-10.02%
$30.95
ETHD
+8.79%
$5.69
DFLI
-1.27%
$0.80
KVUE
-2.61%
$16.22
MARA
-4.00%
$11.51
NIO
-1.29%
$6.08
GOOGL
+3.11%
$285.02
ADAP
-15.14%
$0.05
SNAP
-4.55%
$8.18
PLTR
-1.58%
$171.25
HPE
-7.00%
$21.23
RIG
+1.74%
$4.08
TLRY
-4.62%
$1.03
BURU
-13.34%
$0.21
CIFR
-0.06%
$14.35
AAPL
-1.81%
$267.46
AAL
-3.29%
$12.34
RGTI
-3.10%
$24.69
GRAB
-1.47%
$5.33
WULF
+0.54%
$11.05
ASBP
-14.11%
$0.09
RMBL
+60.50%
$3.21
HOOD
-5.33%
$115.97
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
MSPR
+18.40%
$0.53
AMD
-2.54%
$240.52
WBD
-1.25%
$22.74
BTG
-2.68%
$3.99
BAC
-2.14%
$51.48
CAN
-4.37%
$0.85
XPEV
-10.31%
$22.43
SRM
+53.27%
$10.30
T
-0.46%
$25.47
GOOG
+3.11%
$285.60
NOK
-0.89%
$6.67
IREN
+2.24%
$47.41
SMCI
-6.37%
$34.10
GPUS
-7.60%
$0.27
BBD
-1.63%
$3.62
AMC
-4.82%
$2.17
HIMS
-3.78%
$35.58
PLTD
-1.01%
$6.84
BTBT
-4.56%
$2.30
MU
-1.97%
$241.95
QBTS
-3.30%
$22.83
OWL
-5.81%
$13.77
HBAN
-2.73%
$15.30
BTE
-4.43%
$3.02
SOUN
-6.08%
$11.43
CRWV
-2.62%
$75.33
WLGS
-5.57%
$0.04
CSCO
-0.28%
$77.78
IONZ
-3.07%
$5.04
CLSK
-3.19%
$10.61
VALE
-1.05%
$12.17
MTSR
-0.35%
$70.50
NFLX
-0.83%
$110.29
ABEV
-0.39%
$2.54
APLD
-3.02%
$22.93
EOSE
-5.79%
$13.00
RXRX
-0.48%
$4.12
SMR
-6.19%
$21.06
CLF
+2.23%
$10.97
TWOH
0.00%
$0.00
CRCL
-6.47%
$76.59
AFMD
-34.94%
$0.18
IVVD
+20.85%
$2.84
NBIS
+2.92%
$85.98
QS
-3.57%
$12.95
AMCR
-0.29%
$8.45
KDP
-0.62%
$26.96
JOBY
-3.60%
$13.89
RIOT
-0.50%
$13.88

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.